The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ultrasound Therapy and Manual Therapy in Digital Ischemic Ulcers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05907200
Recruitment Status : Completed
First Posted : June 18, 2023
Last Update Posted : June 22, 2023
Sponsor:
Information provided by (Responsible Party):
Prof.ssa Giulia Letizia Mauro, University of Palermo

Tracking Information
First Submitted Date  ICMJE June 7, 2023
First Posted Date  ICMJE June 18, 2023
Last Update Posted Date June 22, 2023
Actual Study Start Date  ICMJE April 1, 2022
Actual Primary Completion Date November 30, 2022   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: June 18, 2023)
functional capacity [ Time Frame: after 4 weeks of treatment ]
Duruoz's hand index. The total score ranges from 0-90 with higher scores indicating poorer hand functioning.
Original Primary Outcome Measures  ICMJE
 (submitted: June 7, 2023)
functional capacity [ Time Frame: after 4 weeks of treatment ]
Duruoz's hand index
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: June 18, 2023)
  • pain intensity [ Time Frame: after 4 weeks of treatment ]
    numerical rating scale; the total score ranges from 0 to 10, with higher scores indicating more pain.
  • ulcer assessment [ Time Frame: after 4 weeks of treatment ]
    Pressure Sore Status Tool; The score is between 13 and 65. Higher total scores indicated more severe wound status.
  • disease-related quality of life [ Time Frame: after 4 weeks of treatment ]
    The 36-Item Short Form Health Survey; The score ranges from 0 to 100, where higher scores indicate improved health.
Original Secondary Outcome Measures  ICMJE
 (submitted: June 7, 2023)
  • pain intensity [ Time Frame: after 4 weeks of treatment ]
    numerical rating scale
  • ulcer assessment [ Time Frame: after 4 weeks of treatment ]
    Pressure Sore Status Tool
  • disease-related quality of life [ Time Frame: after 4 weeks of treatment ]
    The 36-Item Short Form Health Survey
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Ultrasound Therapy and Manual Therapy in Digital Ischemic Ulcers
Official Title  ICMJE Ultrasound in Combination With Manual Therapy in the Treatment of Ischemic Digital Ulcers in Systemic Sclerosis
Brief Summary

The objective of this before-after non-randomized trial study is to evaluate the efficacy of ultrasound therapy in combination with manual therapy in the management of systemic sclerosis patients with IDU. The main questions it intends to answer are:

• Is this combination of treatments effective in these patients in terms of improvement in hand functional ability, pain relief, injury healing, and quality of life?

Participants will receive rehabilitation treatment consisting of a combination of manual therapy (McMennel joint manipulation, pumping, and connective tissue massage) and US water immersion. The researchers will compare the group of participants, called the treatment group, with a control group to see if:

• Is the combined treatment of ultrasound therapy and manual therapy more effective in these patients than manual therapy alone?

Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Condition  ICMJE Systemic Sclerosis
Intervention  ICMJE
  • Other: combination ultrasound therapy and manual therapy
    The proposed manual therapy lasted 90 minutes and involved a combination of three different techniques: McMennel manipulation, connective tissue massage and mobilization technique of pumping. Patients in the treatment group also received a treatment with US (I-Tech medical device certified UT2 CE0476) in combination with manual therapy. Dipping technique was applied with a frequency of 1 MHz, intensity of 1W/cm2, duty cycle of 60% and a duration of 15 minutes per session.
  • Other: manual therapy
    manual treatment lasting 90 minutes which involved a combination of three different techniques: McMennel manipulation, connective tissue massage and pumping mobilization technique.
Study Arms  ICMJE
  • Experimental: Treatment Group
    It received rehabilitation treatment consisting of a combination of manual therapy (McMennel joint manipulation, pumping and connective tissue massage) and US water immersion.
    Intervention: Other: combination ultrasound therapy and manual therapy
  • Placebo Comparator: Control Group
    It received rehabilitation treatment consisting of manual therapy alone
    Intervention: Other: manual therapy
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: June 7, 2023)
45
Original Actual Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE December 15, 2022
Actual Primary Completion Date November 30, 2022   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • diagnosis of SSc according to the ACR and EULAR criteria
  • presence of IDU in active phase
  • naïve to rehabilitation treatment for their hands and upper limbs
  • written in-formed consent to participate in the study.

Exclusion Criteria:

  • presence of skin lesions due to other conditions (e.g., trauma);
  • pregnancy;
  • infectious diseases (e.g. HIV, HBV, HCV);
  • myositis;
  • arthritis;
  • other rheumatological diseases and immunodepression.
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 30 Years to 60 Years   (Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Italy
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT05907200
Other Study ID Numbers  ICMJE MFR0022023
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: Yes
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Current Responsible Party Prof.ssa Giulia Letizia Mauro, University of Palermo
Original Responsible Party Same as current
Current Study Sponsor  ICMJE University of Palermo
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE Not Provided
Investigators  ICMJE Not Provided
PRS Account University of Palermo
Verification Date June 2023

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP